B2B-RARE

B2B-RARE is a translational research project dedicated to improving the diagnosis and treatment of rare neuromuscular diseases. By integrating cutting-edge cell models, multi-OMICS technologies, and bioinformatics, we aim to better understand disease mechanisms and develop targeted therapeutic strategies.

We invite scientists, clinicians, and industry partners to connect with us and explore collaboration opportunities.

This project is funded by the European Union and the State of North Rhine-Westphalia as part of the EFRE/JTF Program NRW 2021-2027.